Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505136 · ClinicalTrials.gov registry record
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 62
- Enrollment target
NCT05505136: Completed study, sponsored by Zoll Medical Corporation.
NCT05505136 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05505136 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
To determine the associations among biometric data and previously reported medication changes in the original MAPS study
Primary Outcome
Clinical Case Report Form
Interventions
- DEVICE Arrhythmia Management System (AMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2023-05-15 |
What the finished NCT05505136 record still lists
NCT05505136 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Arrhythmia Management System (AMS) is the first listed.
NCT05505136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05505136 about?
NCT05505136 is a clinical study titled "Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes". To determine the associations among biometric data and previously reported medication changes in the original MAPS study
What is the current status of trial NCT05505136?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2022-08-30. Estimated completion is 2023-05-15.
What interventions are being tested in trial NCT05505136?
The interventions under investigation include: Arrhythmia Management System (AMS) (DEVICE).
Who is sponsoring clinical trial NCT05505136?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI